These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8882706

  • 1. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis.
    Sato H, Seiki M.
    J Biochem; 1996 Feb; 119(2):209-15. PubMed ID: 8882706
    [Abstract] [Full Text] [Related]

  • 2. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion.
    Sato H, Okada Y, Seiki M.
    Thromb Haemost; 1997 Jul; 78(1):497-500. PubMed ID: 9198203
    [Abstract] [Full Text] [Related]

  • 3. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
    Fridman R, Toth M, Peña D, Mobashery S.
    Cancer Res; 1995 Jun 15; 55(12):2548-55. PubMed ID: 7780967
    [Abstract] [Full Text] [Related]

  • 4. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity.
    Pei D, Weiss SJ.
    J Biol Chem; 1996 Apr 12; 271(15):9135-40. PubMed ID: 8621565
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
    Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS.
    Cancer Res; 1996 Jan 15; 56(2):384-92. PubMed ID: 8542596
    [Abstract] [Full Text] [Related]

  • 6. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases.
    d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G.
    Eur J Biochem; 1997 Dec 15; 250(3):751-7. PubMed ID: 9461298
    [Abstract] [Full Text] [Related]

  • 7. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y.
    Cancer Res; 1997 May 15; 57(10):2055-60. PubMed ID: 9158005
    [Abstract] [Full Text] [Related]

  • 8. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
    Velasco G, Cal S, Merlos-Suárez A, Ferrando AA, Alvarez S, Nakano A, Arribas J, López-Otín C.
    Cancer Res; 2000 Feb 15; 60(4):877-82. PubMed ID: 10706098
    [Abstract] [Full Text] [Related]

  • 9. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP).
    Sato H, Takino T, Kinoshita T, Imai K, Okada Y, Stetler Stevenson WG, Seiki M.
    FEBS Lett; 1996 May 06; 385(3):238-40. PubMed ID: 8647259
    [Abstract] [Full Text] [Related]

  • 10. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
    Kolkenbrock H, Hecker-Kia A, Orgel D, Ulbrich N, Will H.
    Biol Chem; 1997 Feb 06; 378(2):71-6. PubMed ID: 9088534
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms for pro matrix metalloproteinase activation.
    Murphy G, Stanton H, Cowell S, Butler G, Knäuper V, Atkinson S, Gavrilovic J.
    APMIS; 1999 Jan 06; 107(1):38-44. PubMed ID: 10190278
    [Abstract] [Full Text] [Related]

  • 12. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
    Knäuper V, Will H, López-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G.
    J Biol Chem; 1996 Jul 19; 271(29):17124-31. PubMed ID: 8663255
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.
    Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y.
    Am J Pathol; 1999 Feb 19; 154(2):417-28. PubMed ID: 10027400
    [Abstract] [Full Text] [Related]

  • 17. Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin.
    Sang QA, Bodden MK, Windsor LJ.
    J Protein Chem; 1996 Apr 19; 15(3):243-53. PubMed ID: 8804571
    [Abstract] [Full Text] [Related]

  • 18. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT, Sugiura Y, Laug WE, Sun B, Garcia A, DeClerck YA.
    J Cell Physiol; 1996 May 19; 167(2):333-40. PubMed ID: 8613475
    [Abstract] [Full Text] [Related]

  • 19. Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma.
    Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park CS, Seiki M.
    Cancer; 1997 Jan 01; 79(1):139-44. PubMed ID: 8988738
    [Abstract] [Full Text] [Related]

  • 20. Gelatinases A and B.
    Murphy G, Crabbe T.
    Methods Enzymol; 1995 Jan 01; 248():470-84. PubMed ID: 7674939
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.